Weed (BUDZ) Other financing activities (2017 - 2025)

Weed (BUDZ) recorded quarterly Other financing activities of -$300000.0 in Q1 2025, down 650.0% quarter-over-quarter from -$40000.0 in Q3 2024.

Weed (BUDZ) Other financing activities (2017 - 2025) Analysis & Trends

Weed's Other financing activities history runs 4 years deep, the most recent figure standing at -$300000.0 for Q1 2025.

In Q1 2025, Other financing activities changed N/A year-over-year to -$300000.0; the TTM figure through Mar 2025 stood at -$320000.0 (changed N/A YoY), while the FY2024 annual figure was -$20000.0, changed N/A from the prior year.
Other financing activities was -$300000.0 for Q1 2025 at Weed, down from -$40000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $20000.0 in Q2 2024 to a low of -$300000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Weed	-	-	-

Download Data